pharmacodynamics cefquinme is the fourth generation of cephalosporin antibiotics for animals. by inhibiting the synthesis of cell wall to achieve bactericidal effect, has a broad spectrum antibacterial activity, stable to β-lactamase. in vitro bacteriostatic tests showed that cefquinoxime was sensitive to common gram-positive and gram- negative bacteria. including escherichia coli, citrobacter, klebsiella, pasteurella, proteus, salmonella, serratia marcescens, haemophilus bovis, actinomyces pyogenes, bacillus sPP, corynebacterium, staphylococcus aureus, streptococcus, bacterioid, clostridium, bacillus fusobacterium, prevotella, actinobacillus and erysipelas suis.
pharmacokinetic pigs were injected with 2mg of cefquinoxime intraday per 1kg of body weight, and the blood concentration reached the peak after 0.4 hours, the peak concentration was 5.93µg/ml, the elimination half-life was about 1.4 hours, and the area under the drug curve was 12.34µg · h/ml.
β-lactam antibiotics are used for the treatment of respiratory diseases caused by pasteurella multocida or actinobacillus pleuropneumoniae.
Intramuscular injection: One dose, 0.05ml per 1kg body weight in cattle, 0.08-0.12ml in pigs, once a day, for 3-5 days.
No adverse reactions have been observed according to the prescribed usage and dosage.
1. Animals allergic to beta-lactam antibiotics should not be used.
2. Do not contact this product if you are allergic to penicillin and cephalosporin antibiotics.
3. Shake well before use.
